Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Processa Pharmaceuticals (PCSA)
NASDAQ:PCSA
RESEARCH TOOLSreports
Processa Pharmaceuticals (PCSA) Ownership - Who Owns Processa Pharmaceuticals?
85 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 08, 2024 | David Young Pres. Research & Development,director | Bought | $51450 |
| Feb 07, 2024 | David Young Pres. Research & Development,director | Bought | $50400 |
| Feb 01, 2024 | Patrick Lin Chief Business Strategy Off | Bought | $9525 |
| Jan 31, 2024 | George Ng Ceo,director | Bought | $27000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 331,397 | Institution | 19.41% | 752,271 | |
| 63,105 | Institution | 3.70% | 143,248 | |
| 24,433 | Institution | 1.43% | 55,463 | |
| 13,028 | Institution | 0.76% | 29,574 | |
| 1,898 | Institution | 0.11% | 4,308 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 331,397 | Institution | 19.41% | 752,271 | |
| 63,105 | Institution | 3.70% | 143,248 | |
| 13,028 | Institution | 0.76% | 29,574 | |
| 1,898 | Institution | 0.11% | 4,308 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 24,433 | Institution | 1.43% | 60,105 |
FAQ
Who Owns Processa Pharmaceuticals (PCSA)?
Currently, no data Available
What percentage of Processa Pharmaceuticals (PCSA) stock is held by institutional investors?
Currently, no data Available
What percentage of Processa Pharmaceuticals (PCSA) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Processa Pharmaceuticals (PCSA)?
VANGUARD INDEX FUNDS owns the most shares of Processa Pharmaceuticals (PCSA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.